Published in CA Cancer J Clin on March 29, 2007
Delphinus SoftVue Prospective Case Collection - ARM 2 (SV PCC ARM2) | NCT02977247
A Statewide Intervention to Reduce Use of Unproven or Ineffective Breast Cancer Care | NCT02831439
Delphinus SoftVue Prospective Case Collection - ARM 1 (SV PCC ARM1) | NCT03257839
Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine) | NCT04341129
Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med (2009) 11.96
Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA (2008) 10.92
Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. JAMA (2015) 6.38
Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst (2011) 5.09
Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med (2008) 4.81
Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol (2009) 4.13
High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller. J Clin Oncol (2009) 4.05
Atypical hyperplasia of the breast--risk assessment and management options. N Engl J Med (2015) 3.57
Clinically relevant changes in family history of cancer over time. JAMA (2011) 3.18
Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment. J Clin Oncol (2014) 3.12
Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat Med (2014) 3.09
Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome. J Natl Cancer Inst (2013) 3.06
Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information. J Natl Cancer Inst (2010) 2.82
Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg (2009) 2.79
Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol (2010) 2.77
Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers. J Clin Oncol (2009) 2.74
Breast cancer before age 40 years. Semin Oncol (2009) 2.71
Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood (2010) 2.58
Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol (2008) 2.52
Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancer. JAMA (2009) 2.42
Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst (2009) 2.35
Photoacoustic angiography of the breast. Med Phys (2010) 2.26
Imaging studies for the early detection of breast cancer. Dtsch Arztebl Int (2008) 2.19
Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Ann Intern Med (2010) 2.17
Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666. Radiology (2010) 2.13
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. Int J Cancer (2008) 2.13
Patterns of breast magnetic resonance imaging use in community practice. JAMA Intern Med (2014) 2.08
Impact of gene patents and licensing practices on access to genetic testing for inherited susceptibility to cancer: comparing breast and ovarian cancers with colon cancers. Genet Med (2010) 2.07
General internists' preferences and knowledge about the care of adult survivors of childhood cancer: a cross-sectional survey. Ann Intern Med (2014) 2.03
Ductal carcinoma in situ: X-ray fluorescence microscopy and dynamic contrast-enhanced MR imaging reveals gadolinium uptake within neoplastic mammary ducts in a murine model. Radiology (2009) 2.02
Health behaviors, medical care, and interventions to promote healthy living in the Childhood Cancer Survivor Study cohort. J Clin Oncol (2009) 1.96
Cost-effectiveness of digital mammography breast cancer screening. Ann Intern Med (2008) 1.95
Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine. CA Cancer J Clin (2011) 1.90
Receptor-targeted nanoparticles for in vivo imaging of breast cancer. Clin Cancer Res (2009) 1.86
Rapid increase in breast magnetic resonance imaging use: trends from 2000 to 2011. JAMA Intern Med (2014) 1.85
Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts. Eur Radiol (2009) 1.76
In vivo imaging in cancer. Cold Spring Harb Perspect Biol (2010) 1.76
A pilot study of compositional analysis of the breast and estimation of breast mammographic density using three-dimensional T1-weighted magnetic resonance imaging. Cancer Epidemiol Biomarkers Prev (2008) 1.70
Beyond mammography: new frontiers in breast cancer screening. Am J Med (2013) 1.61
Advances in breast cancer: pathways to personalized medicine. Clin Cancer Res (2008) 1.59
Mammography screening of women in their 40s: impact of changes in screening guidelines. Cancer (2008) 1.54
The magnetic resonance shutter speed discriminates vascular properties of malignant and benign breast tumors in vivo. Proc Natl Acad Sci U S A (2008) 1.53
Principles of cancer screening: lessons from history and study design issues. Semin Oncol (2010) 1.52
Focused ultrasound surgery in oncology: overview and principles. Radiology (2011) 1.51
Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer. Mayo Clin Proc (2010) 1.51
Non-contrast enhanced MRI for evaluation of breast lesions: comparison of non-contrast enhanced high spectral and spatial resolution (HiSS) images versus contrast enhanced fat-suppressed images. Acad Radiol (2011) 1.49
Personalized estimates of breast cancer risk in clinical practice and public health. Stat Med (2011) 1.49
Textural kinetics: a novel dynamic contrast-enhanced (DCE)-MRI feature for breast lesion classification. J Digit Imaging (2011) 1.43
Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.43
Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study. J Clin Oncol (2015) 1.42
Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance. Cancer (2011) 1.41
Molecular breast imaging: use of a dual-head dedicated gamma camera to detect small breast tumors. AJR Am J Roentgenol (2008) 1.39
Improved diagnostic accuracy of breast MRI through combined apparent diffusion coefficients and dynamic contrast-enhanced kinetics. Magn Reson Med (2011) 1.36
Online tool to guide decisions for BRCA1/2 mutation carriers. J Clin Oncol (2012) 1.35
Genetic assessment of breast cancer risk in primary care practice. Am J Med Genet A (2009) 1.35
Breast cancer in young women. Breast Cancer Res (2010) 1.31
Second primary breast cancer occurrence according to hormone receptor status. J Natl Cancer Inst (2009) 1.31
Breast cancer imaging: a perspective for the next decade. Med Phys (2008) 1.29
Yield of screening for long-term complications using the children's oncology group long-term follow-up guidelines. J Clin Oncol (2012) 1.26
Selection of diagnostic features on breast MRI to differentiate between malignant and benign lesions using computer-aided diagnosis: differences in lesions presenting as mass and non-mass-like enhancement. Eur Radiol (2009) 1.24
Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party. Blood (2007) 1.22
Optimization of a dual-energy contrast-enhanced technique for a photon-counting digital breast tomosynthesis system: I. A theoretical model. Med Phys (2010) 1.20
Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers. Breast Cancer Res (2015) 1.20
Development and characterization of an anthropomorphic breast software phantom based upon region-growing algorithm. Med Phys (2011) 1.20
Discrimination of benign and malignant breast lesions by using shutter-speed dynamic contrast-enhanced MR imaging. Radiology (2011) 1.17
Kinetic curves of malignant lesions are not consistent across MRI systems: need for improved standardization of breast dynamic contrast-enhanced MRI acquisition. AJR Am J Roentgenol (2009) 1.17
Genetics of breast cancer: a topic in evolution. Ann Oncol (2015) 1.15
Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer. JAMA (2011) 1.15
Current approaches and challenges in monitoring treatment responses in breast cancer. J Cancer (2014) 1.13
Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors. Nat Rev Clin Oncol (2013) 1.13
Screening and surveillance for second malignant neoplasms in adult survivors of childhood cancer: a report from the childhood cancer survivor study. Ann Intern Med (2010) 1.13
Cryotherapy for breast cancer: a feasibility study without excision. J Vasc Interv Radiol (2009) 1.13
Earlier detection of breast cancer with ultrasound molecular imaging in a transgenic mouse model. Cancer Res (2013) 1.12
Breast cancer detection: radiologists' performance using mammography with and without automated whole-breast ultrasound. Eur Radiol (2010) 1.12
Sensitivity to tumor microvasculature without contrast agents in high spectral and spatial resolution MR images. Magn Reson Med (2009) 1.11
Cancer screening practices among physicians in the national breast and cervical cancer early detection program. J Womens Health (Larchmt) (2011) 1.11
Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence. Breast Cancer Res Treat (2009) 1.10
Unifying screening processes within the PROSPR consortium: a conceptual model for breast, cervical, and colorectal cancer screening. J Natl Cancer Inst (2015) 1.10
Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers. Radiology (2010) 1.09
Multimodality screening of high-risk women: a prospective cohort study. J Clin Oncol (2009) 1.09
Journal club: molecular breast imaging at reduced radiation dose for supplemental screening in mammographically dense breasts. AJR Am J Roentgenol (2015) 1.08
Breast MRI utilization in older patients with newly diagnosed breast cancer. J Surg Res (2011) 1.08
Risk of breast cancer in Lynch syndrome: a systematic review. Breast Cancer Res (2013) 1.08
Breast cancer after chest radiation therapy for childhood cancer. J Clin Oncol (2014) 1.08
Detection of in situ mammary cancer in a transgenic mouse model: in vitro and in vivo MRI studies demonstrate histopathologic correlation. Phys Med Biol (2008) 1.08
Increased risk of breast cancer in women with NF1. Am J Med Genet A (2012) 1.07
Nonmalignant breast lesions: ADCs of benign and high-risk subtypes assessed as false-positive at dynamic enhanced MR imaging. Radiology (2012) 1.07
Development and validation of a primary care-based family health history and decision support program (MeTree). N C Med J (2013) 1.07
Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers. Breast Cancer Res Treat (2010) 1.07
Generation of a suite of 3D computer-generated breast phantoms from a limited set of human subject data. Med Phys (2013) 1.07
What is lacking in current decision aids on cancer screening? CA Cancer J Clin (2013) 1.06
Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress. Clin Genet (2013) 1.05
Individual, provider, and system risk factors for breast and cervical cancer screening among underserved Black, Latina, and Arab women. J Womens Health (Larchmt) (2013) 1.05
Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral. Cancer Epidemiol Biomarkers Prev (2013) 1.05
Breast cancer treatment across health care systems: linking electronic medical records and state registry data to enable outcomes research. Cancer (2013) 1.05
Earlier age of onset of BRCA mutation-related cancers in subsequent generations. Cancer (2011) 1.05
Automated chest wall line detection for whole-breast segmentation in sagittal breast MR images. Med Phys (2013) 1.04
International network of cancer genome projects. Nature (2010) 20.35
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86
Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med (2005) 14.47
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin (2008) 12.90
Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med (2004) 8.91
Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group. Circ Cardiovasc Genet (2010) 6.74
American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin (2010) 6.45
The National Lung Screening Trial: overview and study design. Radiology (2010) 6.43
American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin (2002) 5.56
Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research. Neoplasia (2011) 5.53
Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet (2003) 5.40
An unwelcome side effect of direct-to-consumer personal genome testing: raiding the medical commons. JAMA (2008) 5.25
Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology (2011) 5.17
Effect of population-based screening on breast cancer mortality. Lancet (2011) 5.06
Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA (2006) 4.87
Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen (2010) 4.72
Worldwide variations in colorectal cancer. CA Cancer J Clin (2009) 4.71
American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin (2006) 4.69
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology (2006) 4.57
Screening for breast cancer. JAMA (2005) 4.56
Offering individual genetic research results: context matters. Sci Transl Med (2010) 4.51
American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin (2003) 4.43
Performance benchmarks for screening mammography. Radiology (2006) 4.41
Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med (2011) 4.31
Actionable, pathogenic incidental findings in 1,000 participants' exomes. Am J Hum Genet (2013) 4.06
Magnetic resonance imaging of the breast prior to biopsy. JAMA (2004) 3.97
Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol (2004) 3.86
Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin (2006) 3.67
Supplemental oxygen impairs detection of hypoventilation by pulse oximetry. Chest (2004) 3.55
Reconsidering the family history in primary care. J Gen Intern Med (2004) 3.50
Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts. Ann Intern Med (2014) 3.46
MRI breast screening in high-risk women: cancer detection and survival analysis. Breast Cancer Res Treat (2014) 3.46
Genomic research and wide data sharing: views of prospective participants. Genet Med (2010) 3.45
National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer. Ann Intern Med (2012) 3.44
Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology (2006) 3.42
Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL. Radiology (2012) 3.36
Return of individual research results from genome-wide association studies: experience of the Electronic Medical Records and Genomics (eMERGE) Network. Genet Med (2012) 3.29
Glad you asked: participants' opinions of re-consent for dbGap data submission. J Empir Res Hum Res Ethics (2010) 3.29
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst (2002) 3.25
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin (2006) 3.21
Potential for genetics to promote public health: genetics research on smoking suggests caution about expectations. JAMA (2006) 3.20
ASHG Statement* on direct-to-consumer genetic testing in the United States. Obstet Gynecol (2007) 3.19
American Cancer Society lung cancer screening guidelines. CA Cancer J Clin (2013) 3.16
A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med (2005) 3.01
American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin (2002) 2.94
Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Circulation (2004) 2.91
The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer (2002) 2.85
The efficacy and safety of pain management before and after implementation of hospital-wide pain management standards: is patient safety compromised by treatment based solely on numerical pain ratings? Anesth Analg (2005) 2.83
Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointest Endosc (2007) 2.82
American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin (2007) 2.81
Counterpoint: Overdiagnosis in breast cancer screening. J Am Coll Radiol (2014) 2.75
Volumetric breast density estimation from full-field digital mammograms. IEEE Trans Med Imaging (2006) 2.63
Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer (2010) 2.62
Newborn screening technology: proceed with caution. Pediatrics (2006) 2.54
Identifying women with dense breasts at high risk for interval cancer: a cohort study. Ann Intern Med (2015) 2.46
Breast-tissue composition and other risk factors for breast cancer in young women: a cross-sectional study. Lancet Oncol (2009) 2.45
International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report. J Thorac Oncol (2012) 2.45
Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2006) 2.44
Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer (2008) 2.41
Science and regulation. Regulating direct-to-consumer personal genome testing. Science (2010) 2.40
A formal risk-benefit framework for genomic tests: facilitating the appropriate translation of genomics into clinical practice. Genet Med (2010) 2.40
The genomic applications in practice and prevention network. Genet Med (2009) 2.39
Insights from the breast cancer screening trials: how screening affects the natural history of breast cancer and implications for evaluating service screening programs. Breast J (2014) 2.37
Sequential design approaches for bioequivalence studies with crossover designs. Pharm Stat (2008) 2.33
Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density. Cancer Epidemiol Biomarkers Prev (2005) 2.28
Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. Cancer (2008) 2.28
Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer (2005) 2.25
Breast density legislation and opportunities for patient-centered outcomes research. Radiology (2012) 2.20
Pharmacogenetic testing: not as simple as it seems. Genet Med (2008) 2.18
Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging. J Clin Oncol (2011) 2.17
Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Ann Intern Med (2010) 2.17
Phase I trial of a selective c-MET inhibitor ARQ 197 incorporating proof of mechanism pharmacodynamic studies. J Clin Oncol (2011) 2.14
Mammographic density and breast cancer risk: evaluation of a novel method of measuring breast tissue volumes. Cancer Epidemiol Biomarkers Prev (2009) 2.12
Genomic profiling to promote a healthy lifestyle: not ready for prime time. Nat Genet (2003) 2.11
Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers. Hum Pathol (2013) 2.09
The FDA and genomic tests--getting regulation right. N Engl J Med (2015) 2.09
Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium. Genet Med (2013) 2.08
Identifying minimally acceptable interpretive performance criteria for screening mammography. Radiology (2010) 2.06
Correlates of underutilization of colorectal cancer screening among U.S. adults, age 50 years and older. Prev Med (2003) 2.05
Testing the effect of computer-assisted detection on interpretive performance in screening mammography. AJR Am J Roentgenol (2006) 1.98
Next-generation sequencing in the clinic: are we ready? Nat Rev Genet (2012) 1.95
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res (2013) 1.92
Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value. AJR Am J Roentgenol (2009) 1.91
Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation. Cancer (2008) 1.90
Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology (2006) 1.89
Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow. J Clin Oncol (2003) 1.88
Modelling the cumulative risk of a false-positive screening test. Stat Methods Med Res (2010) 1.87
Promoting early detection tests for colorectal carcinoma and adenomatous polyps: a framework for action: the strategic plan of the National Colorectal Cancer Roundtable. Cancer (2002) 1.87
Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J (2006) 1.85
Minimally invasive pharmacokinetic and pharmacodynamic technologies in hypothesis-testing clinical trials of innovative therapies. J Natl Cancer Inst (2006) 1.83
Influence of annual interpretive volume on screening mammography performance in the United States. Radiology (2011) 1.81
Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed (2002) 1.80